Stock listing
Abcellera Biologics Inc.
- Ticker
- NASDAQ:ABCL
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Abcellera Biologics Inc.
Abcellera Biologics Inc. is a public company traded under the ticker ABCL in the American market. Abcellera focuses on advancing its proprietary technology for antibody discovery and development.
Latest news from Abcellera Biologics Inc.
AbCellera Announces Presentation of Phase 1/2 Data for ABCL635 at TMS 2026 Annual Meeting
Oct 8, 2026
AbCellera to Report Third Quarter 2026 Financial Results on November 9, 2026
Oct 1, 2026
AbCellera Announces Presentation of Phase 2 Data for ABCL635 at the IMS World Congress on Menopause 2026
Sep 16, 2026
AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026
Sep 2, 2026